These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4119343)

  • 21. Sequential administration of hormones for control of conception.
    Dougherty CM
    J La State Med Soc; 1966 Sep; 118(9):382-4. PubMed ID: 4166934
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
    Arnold M; Tóth I; Faredin I
    Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of the effect of oral contraceptives, pregnancy and sex on iron metabolism.
    Mardell M; Symmons C; Zilva JF
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1489-95. PubMed ID: 4186910
    [No Abstract]   [Full Text] [Related]  

  • 24. [The serum levels of nonesterified fatty acids and free amino acids under the effect of the oral contraceptive, Ovosiston].
    Methfessel HD; Mlytz H; Liedtke MP; Löffler F; Methfessel G
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):880-2. PubMed ID: 4098228
    [No Abstract]   [Full Text] [Related]  

  • 25. [Urinary level of metabolites of steroid hormones in women receiving Gestranol].
    Giermańska T; Jablońska K; Filc-Bauer A
    Pol Tyg Lek; 1972 Nov; 27(48):1879-81. PubMed ID: 4118934
    [No Abstract]   [Full Text] [Related]  

  • 26. [The spermatozoa penetration in vivo under ovosiston. (Results of 54 Sims-Huhner tests)].
    Kempf HJ; Müller R; Eckert L
    Zentralbl Gynakol; 1968 Nov; 90(48):1630-9. PubMed ID: 4179432
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral contraceptives, hypertension, and toxemia.
    Carmichael SM; Taylor MM; Ayers CR
    Obstet Gynecol; 1970 Mar; 35(3):371-6. PubMed ID: 4190423
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experiences with Ovosiston for inhibition of ovulation].
    Kühne D
    Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201
    [No Abstract]   [Full Text] [Related]  

  • 29. Electroencephalographic changes during long term treatment with oral contraceptives.
    Matsumoto S; Sato I; Ito T; Matsuoka A
    Int J Fertil; 1966; 11(2):195-204. PubMed ID: 4163250
    [No Abstract]   [Full Text] [Related]  

  • 30. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

  • 31. Endometrial study with combined 17 alpha-hydroxy progesterone contraceptives.
    Hefnawi F; Tagui AH; Askalani AH
    J Egypt Med Assoc; 1971; 54(11):814-21. PubMed ID: 4125870
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of femigen used as a contraceptive on female sexuality].
    Mikrut W
    Wiad Lek; 1982 Jun; 35(10):627-34. PubMed ID: 6182698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Menstruation disorders due to Ovosiston medication].
    Kühndel K; Ebeling K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative studies on endometrial behavior under the effect of various contraceptives].
    Müller R; Bettzieche H; Kempf HJ
    Zentralbl Gynakol; 1972 Dec; 94(52):1821-9. PubMed ID: 4119793
    [No Abstract]   [Full Text] [Related]  

  • 35. [Femigen forte and mite preparations in contraception and gynecologival disorders].
    Sternadel Z; Pietrusiewicz W; Wasilewska B
    Ginekol Pol; 1970 Nov; 41(11):1227-36. PubMed ID: 4098877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vitamin B 12 binding capacity and oral contraceptive hormones.
    Bianchine JR; Bonnlander B; Macaraeg PV; Hersey R; Bianchine JW; McIntyre PA
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1425-8. PubMed ID: 4186909
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiographically verified cerebrovascular disease in young women on oral contraceptives without previous neurological illness.
    Jacobs GB; Foer WH; Ladenheim JC; Pillone PR
    Angiology; 1971 Oct; 22(9):511-20. PubMed ID: 4107250
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives.
    Spellacy WN; Buhi WC; Spellacy CE; Moses LE; Goldzieher JW
    Am J Obstet Gynecol; 1970 Jan; 106(2):173-82. PubMed ID: 4188445
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of oral contraceptives on carbohydrate metabolism.
    Vermeulen A; Daneels R; Thiery M
    Diabetologia; 1970 Oct; 6(5):519-23. PubMed ID: 4097526
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytogenetic studies on women using oral contraceptives and their progeny.
    McQuarrie HG; Scott CD; Ellsworth HS; Harris JW; Stone RA
    Am J Obstet Gynecol; 1970 Oct; 108(4):659-65. PubMed ID: 4096928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.